Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Depreciation & Amortization (CF) of $53.26 million for Q3 2026, down 1.5% from $54.07 million a year earlier but up 11.4% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Amneal Pharmaceuticals was $193.48 million, down 19.5% year-over-year; for FY2025, it came in at $223.57 million, down 5.3% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Depreciation & Amortization (CF) was $236.19 million in FY2024 (+3.0%), $229.4 million in FY2023 (-4.5%), $240.18 million in FY2022 (+2.9%) and $233.41 million in FY2021 (-0.8%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $43.19 million in Q1 2026 to a high of $66.13 million in Q4 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last five quarters, with an average decline of 6.4% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2024, with growth of 16.2%; the weakest was Q1 2026, with a decline of 28.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $47.8 million (Q2 2026), $43.19 million (Q1 2026) and $49.23 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.12 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.61 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.58 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 53.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 53.26 Mn
Jun 30, 2026 47.80 Mn
Mar 31, 2026 43.19 Mn
Dec 31, 2025 49.23 Mn
Sep 30, 2025 54.07 Mn
Jun 30, 2025 60.11 Mn
Mar 31, 2025 60.16 Mn
Dec 31, 2024 66.13 Mn
Sep 30, 2024 58.96 Mn
Jun 30, 2024 55.57 Mn
Mar 31, 2024 55.53 Mn
Dec 31, 2023 56.93 Mn
Sep 30, 2023 57.21 Mn
Jun 30, 2023 57.11 Mn
Mar 31, 2023 58.15 Mn
Dec 31, 2022 61.06 Mn
Sep 30, 2022 61.61 Mn
Jun 30, 2022 59.70 Mn
Mar 31, 2022 57.82 Mn
Dec 31, 2021 61.18 Mn
API Access

Amneal Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMRX&period=max&api_key=YOUR_API_KEY